Dave Ricks

12 statements across 2 episodes · 5 bullish · 2 bearish · 1 people on the record · first statement Oct 8, 2024 by Dave Ricks · said 1 times in 1 episodes since 2024 · across every show →

On the record as a speaker too: Dave Ricks's record, appearances and statements → this page counts the times other people say the name.

Mentions by year

brought up most by Chamath Palihapitiya (1)

mentionsepisodesper episode tap a year for its mentions

2024 1 mention in 1 episode

The All-In Holiday Spectacular Dec 25, 2024 · 1 mention · from 44:35
every mention in 2024, scene by scene →

every mention, scene by scene, with the transcript →

Everything said about Dave Ricks, oldest first

Oct 8, 2024 negative

Prediction Not checkable as stated

Dave Ricks: Fully automated 'in silico' drug discovery is a long way off

“The idea that you're going to throw on, you know, turn a switch on a computer and it's going to think about something and event, you know, the next Prozac. I don't know. I think we're a long way from that day.”

Dave Ricks Oct 8, 2024 ▶ 1:02:25 Dave Ricks, CEO of Eli Lilly | The All-In Interview

Oct 8, 2024

Assertion Contradicted

Dave Ricks: Tech VCs invested $5B in AI drug discovery startups last year

“I think last year, five billion with a B went into new venture backed You know, that's what they like to call themselves. And that money is coming not so much from the traditional bio VC world, but from the tech world. Got a lot more to splash around, right?”

Dave Ricks Oct 8, 2024 ▶ 1:01:20 Dave Ricks, CEO of Eli Lilly | The All-In Interview

Oct 8, 2024 positive

Insight

Dave Ricks: AI's primary drug discovery value is eliminating bad ideas

“It's a co-pilot model where the machine can do predictions. Probably now where we see the most value is Eliminating bad ideas that humans don't see, but in hindsight look obvious. So like, cause you can integrate a lot of multi source data and say the probabil…”

Dave Ricks Oct 8, 2024 ▶ 1:02:44 Dave Ricks, CEO of Eli Lilly | The All-In Interview

Sep 29, 2025

Assertion Not checkable as stated

Dave Ricks estimates 20M people globally take prescription GLP-1 drugs

“I'd estimate around twenty million take prescription GLP-I's.”

Dave Ricks Sep 29, 2025 ▶ 3:36 Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

Sep 29, 2025 bullish

Prediction Open · timeframe Sep 2029

Dave Ricks expects to launch a mental health GLP-1 in 3-4 years

“So we'll get that drug in three or four years if it works, and I think it could really change some of these terrible mental health conditions.”

Dave Ricks Sep 29, 2025 ▶ 20:07 Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

Sep 29, 2025 positive

Disclosure

Dave Ricks personally uses AI models to audit information on his drugs

“I do do it myself. I also do it just to see what the different models are producing about our drugs.”

Dave Ricks Sep 29, 2025 ▶ 24:26 Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

Sep 29, 2025

Assertion Not checkable as stated

Dave Ricks: Brain diseases account for 40% of global human suffering

“I think if you look at human suffering globally, 40% is brain diseases”

Dave Ricks Sep 29, 2025 ▶ 29:33 Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

Sep 29, 2025 positive

Prediction Not checkable as stated

Dave Ricks predicts the next major therapeutic surprise will be brain disease

“It's hard to predict that, but I would say probably a brain disease.”

Dave Ricks Sep 29, 2025 ▶ 29:30 Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

Sep 29, 2025

Assertion Not checkable as stated

Eli Lilly spends over half its consumer advertising budget outside TV

“By the way, more than half of our consumer spending to reach consumers is not on TV.”

Dave Ricks Sep 29, 2025 ▶ 22:58 Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

Sep 29, 2025 positive

Disclosure

Dave Ricks supports reducing direct-to-consumer pharmaceutical advertising

“Well, I would be for a system where we don't have nearly as much drug advertising, to be clear.”

Dave Ricks Sep 29, 2025 ▶ 22:18 Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

Sep 29, 2025 neutral

Disclosure

Eli Lilly completes an external acquisition or partnership roughly every two weeks

“We're doing a deal about every two weeks.”

Dave Ricks Sep 29, 2025 ▶ 12:40 Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

Sep 29, 2025 negative

Assertion Not checkable as stated

Dave Ricks: Poor US insurance coverage drives patients to gray market GLP-1s

“We're not used to it in the United States. Because we, one, have a, for most people, a pretty good system to subsidize some of the benefit via the insurance markets, so there's not a lot of incentive to go outside the system. That's different for these drugs, …”

Dave Ricks Sep 29, 2025 ▶ 5:43 Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

Dave Ricks

Mentions by year

Everything said about Dave Ricks, oldest first

Turn any episode into a week of clips.